Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease
- PMID: 16237174
- PMCID: PMC6725734
- DOI: 10.1523/JNEUROSCI.2980-05.2005
Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease
Abstract
Human amyloid precursor protein (hAPP) transgenic mice with high levels of amyloid-beta (Abeta) develop behavioral deficits that correlate with the depletion of synaptic activity-related proteins in the dentate gyrus. The tyrosine kinase Fyn is altered in Alzheimer's disease brains and modulates premature mortality and synaptotoxicity in hAPP mice. To determine whether Fyn also modulates Abeta-induced behavioral deficits and depletions of synaptic activity-dependent proteins, we overexpressed Fyn in neurons of hAPP mice with moderate levels of Abeta production. Compared with nontransgenic controls and singly transgenic mice expressing hAPP or FYN alone, doubly transgenic FYN/hAPP mice had striking depletions of calbindin, Fos, and phosphorylated ERK (extracellular signal-regulated kinase), impaired neuronal induction of Arc, and impaired spatial memory retention. These deficits were qualitatively and quantitatively similar to those otherwise seen only in hAPP mice with higher Abeta levels. Surprisingly, levels of active Fyn were lower in high expresser hAPP mice than in NTG controls and lower in FYN/hAPP mice than in FYN mice. Suppression of Fyn activity may result from dephosphorylation by striatal-enriched phosphatase, which was upregulated in FYN/hAPP mice and in hAPP mice with high levels of Abeta. Thus, increased Fyn expression is sufficient to trigger prominent neuronal deficits in the context of even relatively moderate Abeta levels, and inhibition of Fyn activity may help counteract Abeta-induced impairments.
Figures









Similar articles
-
Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice.J Neurosci. 2004 May 12;24(19):4692-7. doi: 10.1523/JNEUROSCI.0277-04.2004. J Neurosci. 2004. PMID: 15140940 Free PMC article.
-
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.J Neurosci. 2011 Jan 12;31(2):700-11. doi: 10.1523/JNEUROSCI.4152-10.2011. J Neurosci. 2011. PMID: 21228179 Free PMC article.
-
Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice.J Neurosci. 2005 Oct 19;25(42):9686-93. doi: 10.1523/JNEUROSCI.2829-05.2005. J Neurosci. 2005. PMID: 16237173 Free PMC article.
-
Fyn, a potential target for Alzheimer's disease.J Alzheimers Dis. 2011;27(2):243-52. doi: 10.3233/JAD-2011-110353. J Alzheimers Dis. 2011. PMID: 21799250 Review.
-
Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications.Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18. Mol Neurobiol. 2025. PMID: 38890236 Review.
Cited by
-
The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.Aging Dis. 2015 Mar 10;6(2):131-48. doi: 10.14336/AD.2014.0423. eCollection 2015 Mar. Aging Dis. 2015. PMID: 25821641 Free PMC article. Review.
-
Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.Neurobiol Dis. 2015 Oct;82:372-384. doi: 10.1016/j.nbd.2015.07.008. Epub 2015 Jul 26. Neurobiol Dis. 2015. PMID: 26215784 Free PMC article.
-
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2895-903. doi: 10.1073/pnas.1121081109. Epub 2012 Aug 6. Proc Natl Acad Sci U S A. 2012. PMID: 22869752 Free PMC article.
-
Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking.Neural Plast. 2016;2016:3204519. doi: 10.1155/2016/3204519. Epub 2016 Mar 17. Neural Plast. 2016. PMID: 27073700 Free PMC article. Review.
-
Alzheimer's disease: A prion protein connection.Nature. 2009 Feb 26;457(7233):1090-1. doi: 10.1038/4571090a. Nature. 2009. PMID: 19242462 No abstract available.
References
-
- Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S, Hegde A, Yan SF, Stern A, Luddy JS, Lue LF, Walker DG, Roher A, Buttini M, Mucke L, Li W, Schmidt AM, Kindy M, Hyslop PA, et al. (2004) RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice. EMBO J 23: 4096-4105. - PMC - PubMed
-
- Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD (1998) The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1: 602-609. - PubMed
-
- Bi X, Gall CM, Zhou J, Lynch G (2002) Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience 112: 827-840. - PubMed
-
- Chawla MK, Guzowski JF, Ramirez-Amaya V, Lipa P, Hoffman KL, Marriott LK, Worley PF, McNaughton BL, Barnes CA (2005) Sparse, environmentally selective expression of Arc RNA in the upper blade of the rodent fascia dentata by brief spatial experience. Hippocampus 15: 579-586. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous